Federal Register / Vol. 77, No. 82 / Friday, April 27, 2012 / Notices 25179 

comment must include the factual and legal basis 

for the request, and must identify the specific 

portions of the comment to be withheld from the 

public record. See FTC Rule 4.9(c), CFR 4.9(c), 16 

CFR 4.9(c). 

comment will be kept confidential only 

if the FTC General Counsel, in his or her 

sole discretion, grants your request in 

accordance with the law and the public 

interest. 

Postal mail addressed to the 

Commission is subject to delay due to 

heightened security screening. As a 

result, we encourage you to submit your 

comments online. To make sure that the 

Commission considers your online 

comment, you must file it at https:// 

ftcpublic.commentworks.com/ftc/ 

RegsBEMZpra2 by following the 

instructions on the web-based form. If 

this Notice appears at http:// 

www.regulations.gov/#!home, you also 

may file a comment through that Web 

site. 

If you file your comment on paper, 

write ‘‘Regs BEMZ, PRA Comments, 

P084812’’ on your comment and on the 

envelope, and mail or deliver it to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Room H–113 (Annex J) 600 

Pennsylvania Avenue NW., Washington, 

DC 20580. If possible, submit your 

paper comment to the Commission by 

courier or overnight service. 

Comments on the information 

collection requirements subject to 

review under the PRA should 

additionally be submitted to OMB. If 

sent by U.S. mail, they should be 

addressed to Office of Information and 

Regulatory Affairs, Office of 

Management and Budget, Attention: 

Desk Officer for the Federal Trade 

Commission, New Executive Office 

Building, Docket Library, Room 10102, 

725 17th Street NW., Washington, DC 

20503. Comments sent to OMB by U.S. 

postal mail, however, are subject to 

delays due to heightened security 

precautions. Thus, comments instead 

should be sent by facsimile to (202) 

395–5167. 

Visit the Commission Web site at to 

read this Notice and the news release 

describing it. The FTC Act and other 

laws that the Commission administers 

permit the collection of public 

comments to consider and use in this 

proceeding as appropriate. The 

Commission will consider all timely 

and responsive public comments that it 

receives on or before May 29, 2012. You 

can find more information, including 

routine uses permitted by the Privacy 

Act, in the Commission’s privacy 

policy, at http://www.ftc.gov/ftc/ 

privacy.htm. 

Willard K. Tom, 

General Counsel. 

[FR Doc. 2012–10097 Filed 4–26–12; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: Expired 

Listing for Medkinetics, LLC 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of delisting. 

SUMMARY: AHRQ has accepted a 

notification of expiration from the 

Medkinetics, LLC of its status as a 

Patient Safety Organization (PSO). The 

Patient Safety and Quality Improvement 

Act of 2005 (Patient Safety Act) 

authorizes the listing of PSOs, which are 

entities or component organizations 

whose mission and primary activity is 

to conduct activities to improve patient 

safety and the quality of health care 

delivery. HHS issued the Patient Safety 

and Quality Improvement Final Rule 

(Patient Safety Rule) to implement the 

Patient Safety Act. AHRQ administers 

the provisions of the Patient Safety Act 

and Patient Safety Rule relating to the 

listing and operation of PSOs. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12 Midnight 

ET (2400) on January 6, 2012. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http:// 

www.PSO.AHRQ.qov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: 

PSO@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act, Public Law 

109–41, 42 U.S.C. 299b–21—b–26, 

provides for the formation of PSOs, 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 

delivery. The Patient Safety Rule, 42 

CFR part 3, authorizes AHRQ, on behalf 

of the Secretary of HHS, to list as a PSO 

an entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found to no longer 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule. 

Section 3.108(d) of the Patient Safety 

Rule requires AHRQ to provide public 

notice when it removes an organization 

from the list of federally approved 

PSOs. Accordingly, Medkinetics, LLC, 

PSO number P0036, was delisted 

effective at 12 Midnight ET (2400) on 

January 6, 2012. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.PSO.AHRQ.gov/ 

index.html. 

Dated: April 19, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–10013 Filed 4–26–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Relinquishment From 

Surgical Safety Institute 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of delisting. 

SUMMARY: AHRQ has accepted a 

notification of voluntary relinquishment 

from the Surgical Safety Institute of its 

status as a Patient Safety Organization 

(PSO). The Patient Safety and Quality 

Improvement Act of 2005 (Patient Safety 

Act) authorizes the listing of PSOs, 

which are entities or component 

organizations whose mission and 

primary activity is to conduct activities 

to improve patient safety and the quality 

of health care delivery. HHS issued the 

Patient Safety and Quality Improvement 

Final Rule (Patient Safety Rule) to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule relating to the listing and operation 

of PS0s. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12 Midnight 

ET (2400) on February 21, 2012. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: 

http://www.pso.AHRQ.gov/index.html. 

mstockstill on DSK4VPTVN1PROD with NOTICES

25180 Federal Register / Vol. 77, No. 82 / Friday, April 27, 2012 / Notices 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act, Public Law 

109–41, 42 U.S.C. 299b–21—b–26, 

provides for the formation of PSOs, 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 

delivery. The Patient Safety Rule, 42 

CFR part 3, authorizes AHRQ, on behalf 

of the Secretary of HHS, to list as a PSO 

an entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found to no longer 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule. 

Section 3.108(d) of the Patient Safety 

Rule requires AHRQ to provide public 

notice when it removes an organization 

from the list of federally approved PS0s, 

including when a PSO chooses to 

voluntarily relinquish its status as a 

PSO for any reason. Accordingly, 

Surgical Safety Institute, PSO number 

P0056, was delisted effective at 12:00 

Midnight ET (2400) on February 21, 

2012. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: April 19, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–10012 Filed 4–26–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Immunization 

Practices: Notice of Charter Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

Advisory Committee on Immunization 

Practices, Centers for Disease Control 

and Prevention, Department of Health 

and Human Services, has been renewed 

for a 2-year period through April 1, 

2014. 

For Further Information Contact: 

Larry Pickering, M.D., Designated 

Federal Officer, Advisory Committee on 

Immunization Practices, Centers for 

Disease Control and Prevention, 

Department of Health and Human 

Services, 1600 Clifton Road NE., 

Mailstop A27, Atlanta, Georgia 30333, 

telephone (404) 639–8562 or fax (404) 

639–8626. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 23, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–10214 Filed 4–26–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Conducting Research on 

Moderate Acute Malnutrition in 

Humanitarian Emergencies, Funding 

Opportunity Announcement (FOA) 

GH12–006, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12:30 p.m.–4:30 p.m., May 

22, 2012 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Conducting Research on 

Moderate Acute Malnutrition in 

Humanitarian Emergencies, FOA GH12–006, 

initial review.’’ 

Contact Person for More Information: 

Sheree Williams, Scientific Review Officer, 

Office of the Associate Director for Science, 

Office of Science Quality, CDC, 1600 Clifton 

Road NE., Mailstop D–72, Atlanta, Georgia 

30033, Telephone (404) 639–7742. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 23, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–10260 Filed 4–26–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Evaluation of Dengue 

Epidemiology, Outcomes, and 

Prevention in Sentinel Surveillance and 

Research Sites in Puerto Rico, Funding 

Opportunity Announcement (FOA), 

CK12–001, initial review. 

Correction: The notice was published 

in the Federal Register on January 26, 

2012, Volume 77, Number 17, Page 

4048. The meeting has been rescheduled 

to the following: 

Time and Date: 

1 p.m.–5 p.m., May 4, 2012 (Closed). 

Contact Person for More Information: 

Gregory Anderson, M.P.H., M.S., 

Scientific Review Officer, CDC, 1600 

Clifton Road NE., Mailstop E60, Atlanta, 

Georgia 30333, Telephone: (404) 718– 

8833. The Director, Management 

Analysis and Services Office, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 23, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–10213 Filed 4–26–12; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSK4VPTVN1PROD with NOTICES